ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,703Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 1269

$1.1M Total Retail Price of All Prescriptions

Rank: 14 out of 1269

636 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 636 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 636 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 16,548 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
METOPROLOL TARTRATE 856 752 1 6
AMLODIPINE BESYLATE 806 741 2 2
SIMVASTATIN 791 710 3 3
LEVOTHYROXINE SODIUM 753 673 4 4
METFORMIN HCL 519 449 5 9
OMEPRAZOLE 494 430 6 8
ATORVASTATIN CALCIUM 482 433 7 7
RAMIPRIL 431 335 8 96
LISINOPRIL 410 367 9 1
LOSARTAN POTASSIUM 369 349 10 15
TRAMADOL HCL 346 309 11 16
ENALAPRIL MALEATE 344 298 12 79
HYDROCHLOROTHIAZIDE 331 292 13 10
GLIMEPIRIDE 317 258 14 57
FUROSEMIDE 310 272 15 5
DIOVAN 280 279 16 35
PANTOPRAZOLE SODIUM 266 242 17 18
METOPROLOL SUCCINATE 256 244 18 13
WARFARIN SODIUM 254 233 19 12
TRIAMTERENE-HCTZ 207 179 20 69
AMLODIPINE BESYLATE-BENAZEPRIL 207 183 20 81
CRESTOR 204 165 22 25
TAMSULOSIN HCL 194 192 23 31
HYDROCODONE-ACETAMINOPHEN 194 189 S3 23 20
GABAPENTIN 192 175 25 17
ATENOLOL 179 153 26 14
SERTRALINE HCL 160 122 27 23
CLOPIDOGREL 154 148 28 32
CITALOPRAM HBR 148 135 29 21
DIGOXIN 146 133 30 62
DONEPEZIL HCL 145 134 31 22
MELOXICAM 139 107 32 68
ESCITALOPRAM OXALATE 131 102 33 58
ZOLPIDEM TARTRATE 130 116 34 19
FLUTICASONE PROPIONATE 124 102 35 40
LANTUS SOLOSTAR 123 111 36 144
ISOSORBIDE MONONITRATE ER 121 117 37 63
PROAIR HFA 119 94 38 61
CARVEDILOL 116 102 39 29
SPIRIVA 108 104 40 64
PLAVIX 107 106 41 47
LANTUS 102 91 42 39
BENAZEPRIL HCL 101 93 43 156
ADVAIR DISKUS 100 83 44 46
NEXIUM 100 76 44 41
ALLOPURINOL 99 94 46 49
QUINAPRIL HCL 98 83 47 167
LOSARTAN-HYDROCHLOROTHIAZIDE 96 89 48 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 84 49 33
PRAVASTATIN SODIUM 94 83 50 11
VERAPAMIL ER 93 78 51 134
PREDNISONE 91 77 52 45
AMITRIPTYLINE HCL 90 87 R 53 157
POTASSIUM CHLORIDE 89 81 54 26
SPIRONOLACTONE 89 77 54 77
SYNTHROID 89 80 54 72
LIPITOR 77 67 57 91
CYMBALTA 77 68 57 70
VESICARE 74 71 59 241
ZOSTAVAX 74 63 59 202
RANITIDINE HCL 74 55 59 27
NITROGLYCERIN PATCH 72 72 62 114
DIOVAN HCT 71 66 63 76
NAMENDA 71 71 63 38
PEN NEEDLE 69 57 65 215
NOVOLOG FLEXPEN 68 65 66 182
CELEBREX 66 61 67 95
GLIPIZIDE 66 66 67 37
TRAZODONE HCL 65 65 69 36
TRIAMCINOLONE ACETONIDE 62 59 70 131
LEVOFLOXACIN 58 54 71 75
ALENDRONATE SODIUM 56 53 72 28
TERAZOSIN HCL 55 55 73 111
NOVOLOG 54 52 74 82
FINASTERIDE 54 54 74 112
AZITHROMYCIN 53 47 76 42
FLUOXETINE HCL 50 41 77 83
TRAMADOL HCL-ACETAMINOPHEN 50 32 77 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.